SCHEMBL4900748

SCHEMBL4900748

O=C1CCCN1c1ccc(Nc2cccc(-c3ncc(Cl)s3)n2)nc1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
F10 P00742 3/20 0.37
LMNA P02545 2/20 0.37
HPGD P15428 1/20 0.37
TSHR P16473 1/20 0.37
HPGDS O60760 1/20 0.37
CNR2 P34972 1/20 0.36
MAPK8 P45983 1/20 0.36
MAPK9 P45984 1/20 0.36
MAPK10 P53779 1/20 0.36
HTR6 P50406 1/20 0.36
AKR1C3 P42330 1/20 0.35
CCNT1 O60563 1/20 0.35
CDK4 P11802 1/20 0.35
CCND1 P24385 1/20 0.35
CDK9 P50750 1/20 0.35
CDK6 Q00534 1/20 0.35
CDK11A Q9UQ88 1/20 0.35
GAA P10253 2/20 0.34
PIP4K2A P48426 2/20 0.34
TYK2 P29597 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL5312344 0.99 F10 (0.36) F10LMNAHPGDTSHRHPGDS
SCHEMBL4903017 0.97 F10 (0.40) F10LMNAHPGDTSHRHPGDS
Hydrochloric Acid SCHEMBL4896665 0.87 NPC1 (0.36) LMNAHPGDHPGDSMAPK8MAPK9
SCHEMBL4902865 0.85 AKR1C3 (0.35) HPGDSHTR6AKR1C3GAAPIP4K2A
SCHEMBL4891094 0.85 AKR1C3 (0.35) LMNAHPGDTSHRHPGDSHTR6
SCHEMBL4895704 0.85 F10 (0.36) F10HPGDSHTR6AKR1C3GAA
Hydrochloric Acid SCHEMBL5315908 0.85 CDK6 (0.40) CCNT1CDK4CCND1CDK9CDK6
Hydrochloric Acid SCHEMBL4892965 0.83 PIP4K2A (0.40) HPGDTSHRHPGDSHTR6AKR1C3
SCHEMBL4892130 0.83 CCNA2 (0.44) CCNT1CDK4CCND1CDK9CDK6
SCHEMBL4899219 0.83 F10 (0.35) F10HPGDSHTR6AKR1C3CDK4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080108600-A1 Polycyclic Pyridines as Potassium Ion Channel Modulators ICAGEN, INC. (US) 2008-05-08 US claimed
EP-1737852-A2 POLYCYCLIC PYRIDINES AS POTASSIUM ION CHANNEL MODULATORS Icagen, Inc. (US) 2007-01-03 EP claimed
WO-2005100349-A2 POLYCYCLIC PYRIDINES AS POTASSIUM ION CHANNEL MODULATORS ICAGEN, INC. (US) 2005-10-27 WO claimed
US-20080108600-A1 Polycyclic Pyridines as Potassium Ion Channel Modulators ICAGEN, INC. (US) 2008-05-08 US disclosed
EP-1737852-A2 POLYCYCLIC PYRIDINES AS POTASSIUM ION CHANNEL MODULATORS Icagen, Inc. (US) 2007-01-03 EP disclosed
WO-2005100349-A2 POLYCYCLIC PYRIDINES AS POTASSIUM ION CHANNEL MODULATORS ICAGEN, INC. (US) 2005-10-27 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080108600-A1 Polycyclic Pyridines as Potassium Ion Channel Modulators KCNJ2, KCNH2, KCNQ1 F10 1686/4885LMNA 3338/4885HPGD 1598/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.